We are delighted that Zinforo has received regulatory approval across Europe and believe it will make a valuable contribution to addressing the significant unmet need for new antibiotics. This is a key step in making Zinforo more widely available to pati
and Similar News
Roche Purchases Commercial Rights to Phase 3 Drug
Posted on 2013-02-19 16:21:00 from Motley Fool
In a press release Monday, pharmaceutical giant Roche (NASDAQOTH: RHHBY ) announced that it has agreed with private biotech company Chiasma to develop and commercialize the latter's acromegaly and neuroendocrine tumor therapy Octreolin. Acromegaly is a r
Research Associate/Sr Research Associate - Cancer Immunotherapy
Posted on 2013-02-15 19:38:00 from Nature.com
Who We Are At the Roche Group, about 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. A member of the Roche Group, Genentech has
Seroquel XR patent upheld, protecting AZ blockbuster
Posted on 2013-02-15 14:15:00 from FiercePharma
With basic version falling to generics, AZ has been fighting for XR AstraZeneca's Seroquel XR is one of the key drugs the company banks on.--Courtesy of AstraZeneca AstraZeneca's ($AZN) new CEO Pascal Soriot had to start the year giving shareholders toug
US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed
Posted on 2013-02-15 13:16:00 from Drugs.com
AstraZeneca today announced that, on 14 February 2013, the United States Court of Appeals for the Federal Circuit summarily upheld a lower court ruling that had found the formulation patent protecting SEROQUEL XR (quetiapine fumarate) extended release ta
With a pill for every possible situation, pharmaceutical companies see patients as no more than pound-signs - - The Independent
Posted on 2013-02-15 08:11:00 from PharmaGossip
As if our suffering patients didn’t have it bad enough, now the pharmaceuticals go and announce the failure of yet more drug trials dashing hopes for the million UK sufferers of Alzheimer’s. “Your health is our top concern,” trumpets one pharmaceutical c
U.S. appeals court finds Astra's Seroquel XR patent infringed
Posted on 2013-02-15 01:13:00 from Westlaw Business Currents
Feb 14 (Reuters) - A U.S. appeals court on Thursday upheld a lower court ruling that found the formulation patent for AstraZeneca's anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan Inc and other companies seeking to sell generic